Key Highlights
•
A new deep learning model can accurately classify different types of acute leukemia from microscope images of bone marrow, achieving high accuracy even when tested on images from different hospital lab systems. This tool could help pathologists make faster and more consistent diagnoses, especially for rare or tricky-to-identify leukemia subtypes.
Source →
•
In a large study of children with a rare bone growth disorder, treatment with the drug burosumab was linked to better growth rates and a predicted taller adult height compared to older treatments or no treatment. This real-world evidence confirms the drug’s benefits for improving growth outcomes in kids with X-linked hypophosphatemia.
Source →
•
A study in mice with Alzheimer’s-like pathology found that sleep and daily rhythm problems appeared earlier and more severely in females, and these issues were improved by a drug that calms brain inflammation without reducing amyloid plaques. This suggests that targeting inflammation could be a quick way to treat sleep disturbances in Alzheimer’s, which are more common in women.
Source →
•
For chronic pain in the sacroiliac joint (a common cause of low back pain), procedures using radiofrequency energy to disable pain nerves were more effective for pain relief at 1, 3, and 6 months than steroid injections or standard care. This analysis helps guide doctors toward more effective interventional treatments for this stubborn type of back pain.
Source →
•
A national study in the UK found that nearly one in five patients sought extra medical help for pain after day-case surgery, often from their family doctor, creating a significant burden on community health services. While most patients were satisfied with their pain relief, the findings highlight a need for better support systems for patients recovering at home after outpatient procedures.
Source →
•
Higher levels of a specific bile acid called deoxycholic acid in the blood were linked to a greater presence and severity of painful hand osteoarthritis in two separate groups of patients. This discovery connects gut microbiome health and its metabolites to joint disease, opening new avenues for understanding and potentially treating osteoarthritis.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
